Financial Performance - Sales for Q2 2024 were 453million,a638.9 million, up 6.2millionfromthepreviousyear,withadjustedearningspershareof1.55, a 24% increase year-over-year[2][6]. - Adjusted EBITDA was 78.1million,reflectinga19453,479,000, an increase of 5.8% compared to 427,940,000forthesameperiodin2023[19].−NetincomeforthethreemonthsendedJune30,2024,was38,927,000, representing a 19% increase from 32,728,000intheprioryear[19].−BasicearningspershareforthethreemonthsendedJune30,2024,were1.45, up from 1.19forthesameperiodin2023,reflectinga21.842,090 million, compared to 35,198millionintheprioryear,reflectinga1978,141 million, compared to 65,785millioninthesameperiodlastyear,markinga191.45, an increase from 1.19inthesameperiodof2023,representingagrowthof221.43, compared to 1.16intheprioryear,reflectinga231.57, up from 1.28inthesameperiodof2023,reflectingagrowthof2350.2 million, an increase of 43% year-over-year, while free cash flow was 16.7million,up1.0 million[2][6]. - Capital expenditures for the quarter were 33.5million,anincreaseof14.2 million compared to the prior year, reflecting planned spending on maintenance and growth projects[2][6]. - Capital expenditures for 2024 are expected to be between 140millionand150 million, focusing on risk mitigation and growth projects[7]. - Free cash flow for the three months ended June 30, 2024, was 16,705,000,comparedto15,713,000 for the same period in 2023, an increase of 6.3%[25]. Shareholder Returns - The company returned 8milliontoshareholdersthroughdividendsandstockrepurchasesinQ22024[2].−TheBoardofDirectorsdeclaredaquarterlycashdividendof0.16 per share, payable on August 27, 2024[8]. Assets and Liabilities - Total current assets decreased to 378,592,000asofJune30,2024,downfrom419,804,000 at December 31, 2023, a decline of 9.8%[16]. - Total liabilities decreased to 731,353,000asofJune30,2024,comparedto756,783,000 at December 31, 2023, a reduction of 3.4%[16]. - Cash and cash equivalents at the end of the period were 12,105,000,downfrom29,768,000 at the end of 2023, a decrease of 59.3%[16]. - The company’s retained earnings increased to 617,723,000asofJune30,2024,upfrom605,067,000 at December 31, 2023, reflecting a growth of 2.7%[16]. Market Outlook - The company anticipates higher ammonium sulfate pricing in Q3 2024 due to robust demand, although a sequential pricing decline is expected due to typical seasonality[7]. - The company is positioned for favorable second-half performance, supported by a constructive global acetone supply and demand environment[7]. Expenses - Total costs and expenses for the three months ended June 30, 2024, were 401,407,000,upfrom384,657,000 in the same period last year, an increase of 4.3%[19]. - The company reported a net cash provided by operating activities of 50,200,000forthethreemonthsendedJune30,2024,comparedto35,004,000 for the same period in 2023, an increase of 43.4%[22]. - The company reported an interest expense of 3,514millionforthethreemonthsendedJune30,2024,comparedto1,954 million in the same period last year, indicating a significant increase[27].